A4GNT | Alpha-1,4-N-acetylglucosaminyltransferase | Predicted secreted proteins
| | | | | Tissue enriched |
ABHD11 | Abhydrolase domain containing 11 | Disease related genes
| | | | | Expressed in all |
ABHD8 | Abhydrolase domain containing 8 | | | | | | Mixed |
ABR | Active BCR-related | | | | | | Expressed in all |
ABTB1 | Ankyrin repeat and BTB (POZ) domain containing 1 | | | | | | Expressed in all |
ABTB2 | Ankyrin repeat and BTB (POZ) domain containing 2 | | | | | | Mixed |
ACADL | Acyl-CoA dehydrogenase, long chain | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Mixed |
ACR | Acrosin | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
ACRBP | Acrosin binding protein | Predicted secreted proteins
| | | | | Tissue enriched |
ACSM5 | Acyl-CoA synthetase medium-chain family member 5 | Enzymes Mitochondrial proteins
| | | | | Tissue enriched |
ACTL7B | Actin-like 7B | | | | | | Tissue enriched |
ACTRT2 | Actin-related protein T2 | Cytoskeleton related proteins
| | | | | Tissue enriched |
ADAM20 | ADAM metallopeptidase domain 20 | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
ADAM21 | ADAM metallopeptidase domain 21 | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
ADAMTS20 | ADAM metallopeptidase with thrombospondin type 1 motif, 20 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Not detected |
ADCK5 | AarF domain containing kinase 5 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
ADGB | Androglobin | Enzymes
| | | | | Group enriched |
ADPRHL1 | ADP-ribosylhydrolase like 1 | | | | | | Group enriched |
AIM1L | Absent in melanoma 1-like | | | | | | Tissue enhanced |
AKNAD1 | AKNA domain containing 1 | | | | | | Tissue enhanced |
AKR1B15 | Aldo-keto reductase family 1, member B15 | | | | | | Tissue enhanced |
ALLC | Allantoicase | Enzymes
| | | | | Tissue enriched |
ALPK1 | Alpha-kinase 1 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
ALPK2 | Alpha-kinase 2 | Cancer-related genes Enzymes
| | | | | Tissue enhanced |
AMIGO3 | Adhesion molecule with Ig-like domain 3 | Predicted membrane proteins
| | | | | Mixed |
ANKEF1 | Ankyrin repeat and EF-hand domain containing 1 | | | | | | Tissue enhanced |
ANKRD13C | Ankyrin repeat domain 13C | | | | | | Expressed in all |
ANKRD34A | Ankyrin repeat domain 34A | | | | | | Tissue enriched |
ANKRD45 | Ankyrin repeat domain 45 | | | | | | Tissue enhanced |
ANKRD65 | Ankyrin repeat domain 65 | | | | | | Tissue enhanced |
ANKS3 | Ankyrin repeat and sterile alpha motif domain containing 3 | | | | | | Expressed in all |
ANO4 | Anoctamin 4 | Predicted membrane proteins
| | | | | Tissue enhanced |
AQP12A | Aquaporin 12A | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
AQP12B | Aquaporin 12B | Predicted membrane proteins
| | | | | Tissue enriched |
AQP3 | Aquaporin 3 (Gill blood group) | Blood group antigen proteins Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
AQP6 | Aquaporin 6, kidney specific | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
ARHGAP40 | Rho GTPase activating protein 40 | | | | | | Group enriched |
ARHGDIG | Rho GDP dissociation inhibitor (GDI) gamma | | | | | | Tissue enhanced |
ARHGEF33 | Rho guanine nucleotide exchange factor (GEF) 33 | | | | | | Tissue enhanced |
ARMC3 | Armadillo repeat containing 3 | | | | | | Group enriched |
ARMCX6 | Armadillo repeat containing, X-linked 6 | Predicted membrane proteins
| | | | | Expressed in all |
ASTE1 | Asteroid homolog 1 (Drosophila) | | | | | | Mixed |
ATG16L2 | Autophagy related 16-like 2 (S. cerevisiae) | | | | | | Expressed in all |
ATP10D | ATPase, class V, type 10D | Enzymes Predicted membrane proteins
| | | | | Mixed |
ATP6V0D2 | ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2 | | | | | | Tissue enriched |
ATP6V1E2 | ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2 | | | | | | Expressed in all |
ATP6V1G3 | ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3 | Transporters
| | | | | Tissue enriched |
AZIN1 | Antizyme inhibitor 1 | | | | | | Expressed in all |
B3GNT7 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 | Predicted secreted proteins
| | | | | Tissue enhanced |
BAI2 | Brain-specific angiogenesis inhibitor 2 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |